Phase 1 cancer studies
Phase 1 cancer trials, on your terms
We are Phase 1 Cancer Trials. We help you learn about Phase 1 cancer trials, and if you are interested, we connect you with the study teams. The first step is a short conversation. It costs nothing and places you under no obligation.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed

Phase 1 cancer studies in numbers
- Phase 1 cancer studies recruiting in the U.S.
- 1,009
- states with a study site
- 49
- cities with a study site
- 393
- studies that accept healthy volunteers
- 18
Source: ClinicalTrials.gov. Data processed .
Find Phase 1 cancer studies near you
These states have the most studies recruiting right now.
Texas
406 studies recruiting.
California
377 studies recruiting.
New York
298 studies recruiting.
Florida
240 studies recruiting.
Ohio
194 studies recruiting.
All locations
Browse every state and city with a recruiting study.
Phase 1 cancer studies recruiting now
As of November 17, 2026, 1,009 Phase 1 cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry. This is what they have in common.
What they test
- medications862
- biologics such as vaccines or antibodies206
- procedures131
- radiation51
- other approaches41
A study can test more than one.
Main purpose
- treating a condition928
- diagnosis44
- basic science8
- supportive care8
Phase
- Early Phase 160
- Phase 1540
- Phase 1/2409
Who runs them
- industry523
- university, hospital or other444
- government42
Who they enroll
- adults (18 to 64)1,005
- older adults (65 and over)962
- children (under 18)83
18 also accept healthy volunteers.
Where: sites in 49 states. The cities with the most are Houston, TX (276), New York, NY (247), Boston, MA (178), Nashville, TN (173), Los Angeles, CA (156), Fairfax, VA (148), San Antonio, TX (118), Duarte, CA (109).
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 1,009 studies.
Recruiting now, by research area
- Breast Cancer: 246 studies recruiting in the United States.
- Lung Cancer: 330 studies recruiting in the United States.
- Prostate Cancer: 161 studies recruiting in the United States.
- Melanoma: 106 studies recruiting in the United States.
- Lymphoma: 283 studies recruiting in the United States.
- Pancreatic Cancer: 166 studies recruiting in the United States.
Recently updated Phase 1 cancer studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
- Phase 1
- Ages 12 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda, MD · Fairway, KS
- Registry record
- NCT04222413 · updated
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Vivace Therapeutics, Inc
- Recruiting in
- Arlington, VA · Boston, MA · Chicago, IL · and 5 more U.S. locations
- Registry record
- NCT04665206 · updated
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Recruiting in
- Akron, OH · Albany, NY · Albuquerque, NM · and 129 more U.S. locations
- Registry record
- NCT04726241 · updated
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
- Phase 1
- Ages 18 and older
- Female participants
- Sponsor
- Totus Medicines
- Recruiting in
- Boston, MA · Calverton, MD · Chicago, IL · and 5 more U.S. locations
- Registry record
- NCT05683418 · updated
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Debiopharm International SA
- Recruiting in
- Chicago, IL · Dallas, TX · Houston, TX · and 4 more U.S. locations
- Registry record
- NCT05765812 · updated
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Recruiting in
- Boston, MA · Cleveland, OH · Durham, NC · and 14 more U.S. locations
- Registry record
- NCT05786924 · updated
Source: ClinicalTrials.gov. Data processed .
Not sure which study fits?
Tell a coordinator what you are looking for. They will explain which Phase 1 cancer studies may be worth a closer look and what the next step is. Asking does not commit you to anything.
How taking part works
The process has four steps. At each one, you choose whether to go on to the next.
Tell us what you are looking for
The first step is a phone call or a brief form. We ask only which cancer, or which kind of Phase 1 trial, you are looking into.
Talk with a coordinator
A coordinator talks you through the Phase 1 cancer trials that may be a match. Your questions are answered in plain language.
Meet the study team
Continuing is up to you. If you say yes, the people running the Phase 1 trial explain it to you point by point, and your eligibility is theirs to assess.
Decide what is right for you
Joining a study is voluntary, always. If you change your mind, you can leave at any time and for any reason.
Research areas
These are the areas of cancer research where we help you explore studies.
Breast Cancer studies
Breast cancer research takes several forms. Some studies examine investigational medications, some combine therapies already in use, and others focus on screening or supportive-care approaches.
Lung Cancer studies
In lung cancer, researchers study investigational medications, approaches to radiation, and screening methods. The work spans different types and stages of lung cancer.
Prostate Cancer studies
Studies in prostate cancer assess investigational medications along with methods of imaging and monitoring. They cover the disease across its stages.
Melanoma studies
Melanoma is a form of skin cancer. Studies in this area examine investigational immunotherapies, targeted medications, and combinations.
Lymphoma studies
Lymphoma research covers both Hodgkin and non-Hodgkin lymphoma. Studies evaluate investigational medications and cell-based approaches.
Pancreatic Cancer studies
In pancreatic cancer, studies look at investigational medications, therapies used in combination, and methods of early detection.
Not sure where you fit?
A coordinator can point you in the right direction. All we need is a little information about what you are looking for.
Why people take part in Phase 1 cancer studies
Reasons for joining a Phase 1 cancer trial differ from person to person. Each one is a sound reason, and each merits a conversation with us or with the study team before you make up your mind.
- Some people want a research team following their health closely while the study runs.
- Some hope to learn more about the cancer they are living with.
- Some want to help researchers answer questions whose results could inform how others are cared for later on.
Research and treatment are not the same thing. A Phase 1 trial is research, so a personal benefit from taking part is something no one is able to promise you. Our page on what a clinical trial is explains this in plain terms.
Your safety and your rights come first
Independent ethics committee review comes first for every Phase 1 study, and enrollment cannot open until that review is done. You are handed the written details before anyone asks for your agreement on any point. Our guides explain how informed consent works, how studies are reviewed and monitored, and which rights you keep from start to finish.
Common questions about Phase 1 cancer studies
Does it cost anything to ask about a study?
No. A conversation with Phase 1 Cancer Trials costs you nothing. Asking us questions does not enroll you in anything.
Do I have to take part if I call?
No. Each stage brings a fresh choice about going on, and that choice belongs to you. You are free to stop at any point.
Who decides whether I can join a study?
The study team does. They make that call once you have had a screening visit, and every Phase 1 trial sets requirements of its own. Our guide to eligibility and screening describes the process.
Ask about Phase 1 cancer studies
A coordinator will contact you once you share a few details. Asking about a Phase 1 cancer trial does not commit you to anything.
Learn more from independent sources
- What Are Clinical Trials and Studies? — National Institute on Aging (NIH)
- About Research Participation — HHS Office for Human Research Protections
- Learn About Studies — ClinicalTrials.gov (National Library of Medicine)